This case study displays the successful application of Prolonged Exposure (PE) for a client with diagnoses of Posttraumatic Stress Disorder (PTSD), Attention Deficit Hyperactivity Disorder (ADHD), and Generalized Anxiety Disorder (GAD). To our knowledge ADHD has not been examined as a predictor or moderator of PE outcomes. As such, practitioners have precious little information about how to proceed in such cases, which highlights the importance of careful individual assessment and case conceptualization. There is also a dearth of information on the effects of combining PE (a research-supported psychological intervention for PTSD) with psychostimulant medication (a research-supported pharmacological intervention for ADHD). The present case study illustrates a positive synergy between psychostimulant treatment and PE. The unique adjustments made to deliver services (including in the face of COVID-19) are described as well as what this case suggests about the effects of psychostimulant use on PTSD symptoms and the new learning that occurs during PE.
Aga-MizrachiS.Cymerblit-SabbaA.GurmanO.BalanA.SchwamG.DesheR.MillerL.GorodetskyN.HeinrichN.TzezanaO.ZubedatS.GrinsteinD.AvitalA. (2014). Methylphenidate and desipramine combined treatment improves PTSD symptomology in a rate model. Translational Psychiatry, 4(9), 1–9.
2.
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (DSM-5®). American Psychiatric Publishing.
3.
AntshelK.KaulP.BiedermanJ.SpencerT.HierB.HendricksK.FaraoneS. (2013). Posttraumatic stress disorder in adult attention-deficit/hyperactivity disorder: Clinical features and familial transmission. Journal of Clinical Psychiatry, 74(3), 197–204.
4.
BenjetC.BrometE.KaramE.KesslerR.McLaughlinK.RuscioA.ShahlyV.SteinD.PetukhovaM.HillE.AlonsoJ.AtwoliL.BuntingB.BruffaertsR.Caldas-de-AlmeidaJ.de GirolamoG.FlorescuS.GurejeO.HuangY.… KoenenK. C. (2016). The epidemiology of traumatic event exposure worldwide: Results from the World Mental Health Survey Consortium. Psychological Medicine, 46(2), 327–343.
5.
BlevinsC.WeathersF.DavisM.WitteT.DominoJ. (2015). The posttraumatic stress disorder checklist for dsm-5 (pcl-5): Development and initial psychometric evaluation. Journal of Traumatic Stress, 28, 489–498.
6.
CorteseS.AdamoN.Del GiovaneC.Mohr-JensenC.HayesA. J.CarucciS.AtkinsonL. Z.TessariL.BanaschewskiT.CoghillD.HollisC.SimonoffE.ZuddasA.BarbuiC.PurgatoM.SteinhausenH. C.ShokranehF.XiaJ.CiprianiA. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. Lancet Psychiatry, 5(9), 727–738.
7.
CoughlinC.CohenS.MulqueenJ.Ferracioli-OdaE.StuckelmanZ.BlochM. (2015). Meta-analysis: Reduced risk of anxiety with psychostimulant treatment in children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 25(8), 611–617.
8.
DaddsM. R.FrickP. J. (2019). Toward a transdiagnostic model of common and unique processes leading to the major disorders of childhood: The REAL model of attention, responsiveness and learning. Behaviour Research and Therapy, 119, 103410.
9.
DeslauriersJ.TothM.ZhouX.RisbroughV. (2019). Heritable differences in catecholamine signaling modulate susceptibility to trauma and response to methylphenidate treatment: Relevance for PTSD. Frontiers in Behavioral Neuroscience, 13(111), 1–13.
10.
FaraoneS. V.BiedermanJ.MickE. (2006). The age-dependent decline of attention deficit hyperactivity disorder: A meta-analysis of follow-up studies. Psychological Medicine, 36(2), 159–165.
11.
FloryJ. D.YehudaR. (2015). Comorbidity between post-traumatic stress disorder and major depressive disorder: alternative explanations and treatment considerations. Dialogues in Clinical Neuroscience, 17(2), 141–150.
12.
FoaE.HembreeE.RothbaumB.RauchS. (2019). Prolonged exposure therapy for PTSD: Emotional processing of traumatic experiences – Therapist guide. Oxford University Press.
13.
Galatzer-LevyI.NickersonA.LitzB.MarmarC. (2012). Patterns of lifetime PTSD comorbidity: A latent class analysis. Depression and Anxiety, 30(5), 489–496.
14.
GallagherM.BrownT. (2015). Bayesian analysis of current and lifetime comorbidity rates of mood and anxiety disorders in individuals with posttraumatic stress disorder. Journal of Psychopathology and Behavioral Assessment, 37(1), 60–66.
15.
GhafooriB. (2018). Prolonged exposure therapy for experiential avoidance: A case-series study. Clinical Case Studies, 17(3), 123–135.
16.
HaavikJ.HalmoyA.LundervoldA.FasmerO. (2010). Clinical assessment and diagnosis of adults with attention-deficit/hyperactivity disorder. Expert Review of Neurotherapeutics, 10(10), 1569–1580.
17.
HarringtonK.MillerM.WolfE.ReardonA.RyabchenkoK.OfratS. (2012). Attention-deficit/hyperactivity disorder comorbidity in a sample of veterans with posttraumatic stress disorder. Comprehensive Psychiatry, 53(6), 679–690.
18.
KesslerR.BerglundP.DelmerO.JinR.MerikangasK.WaltersE. (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry, 62(6), 593–602.
19.
McAllisterT.ZafonteR.JainS.FlashmanL.GeorgeM.GrantG.HeF.LohrJ.AndaluzN.SummerallL.PaulusM.RamanR.SteinM. (2016). Randomized placebo-controlled trial of methylphenidate or galantamine for persistent emotional and cognitive symptoms associated with PTSD and/or traumatic brain injury. Neuropsychopharmacology, 41(5), 1191–1198.
20.
MehtaD.KlengelT.ConneelyK. NSmithA. KAltmannA.PaceT. W.Rex-HaffnerM.LoeschnerA.GonikM.MercerK. B.BradleyB.Müller-MyhsokB.ResslerK. J.BinderE. B. (2013). Childhood maltreatment is associated with distinct genomic and epigenetic profiles in posttraumatic stress disorder. Proceedings for the National Academy of Sciences, 110(20), 8302–8307.
21.
MinnenA.HarnedM.ZoellnerL.MillsK. (2012). Examining potential contraindications for prolonged exposure therapy for PTSD. European Journal of Psychotraumatology, 3(1), 18805–18814.
22.
ParsonsR. G.ResslerK. J. (2013). Implications of memory modulation for post-traumatic stress and fear disorders. Nature Neuroscience, 16, 146–153.
23.
PowersM.HalpernJ.FerenschakM.GillihanS.FoaE. (2010). A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clinical Psychology Review, 30(6), 635–641.
24.
ReimherrF.MarchantB.GiftT.SteansT. (2017). ADHD and anxiety: Clinical significance and treatment implications. Current Psychiatry Reports, 19(12), 1–10.
25.
RuglassL.Lopez-CastroT.PapiniS.KilleenT.BackS.HienD. (2017). Concurrent treatment with prolonged exposure for co-occurring full or subthreshold posttraumatic stress disorder and substance use disorders: A randomized clinical trial. Psychotherapy and Psychosomatics, 86(3), 150–161.
26.
SafrenS. A.SprichS.ChulvickS.OttoM. W. (2004). Psychosocial treatments for adults with attention-deficit/hyperactivity disorder. Psychiatric Clinics of North America, 27(2), 349–360.
27.
SibleyM.WaxmonskyJ.RobbJ.PelhamW. (2013). Implications of changes for the field: ADHD. Journal of Learning Disabilities, 46(1), 34–42.
28.
SpencerA. E.FaraoneS. V.BoguckiO. E.PopeA. L.UchidaM.MiladM. R.SpencerT. J.WoodworthK. Y.BiedermanJ. (2016). Examining the association between posttraumatic stress disorder and attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Journal of Clinical Psychiatry, 77(1), 72–83.
29.
WalkerR.MarksE.JaegarJ.DuaxJFeenyN.ZoellnerL. (2020). Imaginal exposure exacerbation revisited: Deconstructing patient characteristics associated with worse reactions to the initiation of imaginal exposure in PTSD. Behavior Research and Therapy, 135, 103747.
30.
WangY.-P.GorensteinC. (2013). Psychometric properties of the beck depression inventory-ii: A comprehensive review. Revista Brasileira De Psiquiatria, 35(4), 416–431.
31.
WeathersF. W.LitzB. T.KeaneT. M.PalmieriP. A.MarxB. P.SchnurrP. P. (2013). The PTSD Checklist for DSM-5 (PCL-5). Scale available from the National Center for PTSD at www.ptsd.va.gov.
32.
WellsS. Y.MorlandL. A.WilhiteE. R.GrubbsK. M.RauchS. A. M.AciernoR.McLeanC. P. (2020). Delivering prolonged exposure therapy via videoconferencing during the COVID-19 pandemic: An overview of the research and special considerations for providers. Journal of Traumatic Stress, 33, 380–390.
